Show
Sort by
-
Epigenetic assay stratifies prostate cancer patients' risk for aggressiveness
-
Risk stratification of aggressive prostate cancer based on combined epigenetic and clinical data of men with initial cancer-negative biopsies
-
Epigenetic profiling of prostate cancer tissue to identify men with high-risk disease
-
Prediction of risk for prostate cancer in histopathologically negative biopsies by multigene epigenetic assay
-
Clinical utility of an epigenetic assay to detect occult prostate cancer in histopathologically negative biopsies: results of the MATLOC study
-
- Journal Article
- A1
- open access
A tissue biopsy-based epigenetic multiplex PCR assay for prostate cancer detection